Total Funding
31
55
Total FundingSeries C raised
Growth Score 31 in past quarter
-1 pts
Heat Score 55 in past quarter
7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
103367
Endosphere develops non-invasive medical devices used for treating metabolic diseases.
Kenneth Binmoeller: Founder & Chief Medical OfficerPast Role: Xlumena, Founder & Chief Medical Officer- Fiona Sander: Vice President of Product Research & Development
About the Company
Endosphere is a developer of the novel endo-metabolic device category that provides non-invasive endoscopic therapies for gastrointestinal (GI) disorders and metabolic diseases including obesity, non-alcoholic fatty liver disease, type 2 diabetes, and drug delivery. It treats obesity using the body's natural physiology that enables patients
to safely and effectively lose weight without the need for surgery or medications.
Endosphere was founded in 2006 and is headquartered in Columbus, Ohio.

